Lana Medical Company (TADAWUL:9587)

Lana Medical Company Income Statement

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	98.14	84.09	48.63	40.8	31.97
Revenue Growth (YoY)	61.90%	72.89%	19.20%	27.64%	-
Cost of Revenue	82.16	59.19	29.42	21.93	15.1
Gross Profit	15.99	24.9	19.21	18.87	16.87
Selling, General & Admin	8.03	15.3	11.61	9.04	8.47
Operating Expenses	9.15	16.42	19.58	12.35	9.55
Operating Income	6.84	8.48	-0.37	6.52	7.32
Interest Expense	-0.28	-0.48	-0.34	-0.2	-0.08
Earnings From Equity Investments	5.37	5.37	-	-	-
Other Non Operating Income (Expenses)	0.25	0.25	0.18	0.29	0.54
EBT Excluding Unusual Items	12.18	13.62	-0.52	6.62	7.78
Gain (Loss) on Sale of Assets	-	-	-	-	0.01
Pretax Income	12.18	13.62	-0.52	6.62	7.79
Income Tax Expense	0.96	1.16	1.41	1.13	1.2
Net Income	11.22	12.46	-1.93	5.49	6.59
Net Income to Common	11.22	12.46	-1.93	5.49	6.59
Net Income Growth	253.72%	-	-	-16.70%	-
Shares Outstanding (Basic)	54	54	46	45	33
Shares Outstanding (Diluted)	54	54	46	45	33
Shares Change (YoY)	7.21%	18.38%	1.37%	37.11%	-
EPS (Basic)	0.21	0.23	-0.04	0.12	0.20
EPS (Diluted)	0.21	0.23	-0.04	0.12	0.20
EPS Growth	229.93%	-	-	-39.25%	-
Free Cash Flow	-11.78	-3.73	-2.43	0.5	-12.17
Free Cash Flow Per Share	-0.22	-0.07	-0.05	0.01	-0.37
Gross Margin	16.29%	29.61%	39.50%	46.25%	52.76%
Operating Margin	6.97%	10.08%	-0.76%	15.99%	22.90%
Profit Margin	11.43%	14.82%	-3.96%	13.46%	20.63%
Free Cash Flow Margin	-12.00%	-4.43%	-5.00%	1.22%	-38.06%
EBITDA	9.85	11.18	1.11	7.54	8.09
EBITDA Margin	10.03%	13.29%	2.29%	18.47%	25.30%
D&A For EBITDA	3.01	2.7	1.48	1.01	0.77
EBIT	6.84	8.48	-0.37	6.52	7.32
EBIT Margin	6.97%	10.08%	-0.76%	15.99%	22.90%
Effective Tax Rate	7.91%	8.51%	-	17.03%	15.36%
Advertising Expenses	-	0.35	0.33	0.19	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.